The table below shows drug alerts, medicines recalls and company-led drug alerts issued by the Medicines and Healthcare products Regulatory Agency (MHRA) and other relevant organisations such as the Department of Health and Social Care (DHSC) on behalf of medicines manufacturers.

The information in this table is listed in reverse chronological order and will be updated on an ongoing basis.

Medicines recalls Drug alerts Company-led drug alerts/recalls Supply disruption alerts
Class 2 Medicines Recall: Esmya tablets 5mg

Class 2 Medicines Recall: Emerade 150 mcg solution for injection in pre-filled syringe

Class 2 pharmacy level medicines recall – Gliclazide tablets 40mg – Action within 48 hours

Class 3 Falsified Medicines Directive (FMD) recall – Beconase Aqueous Nasal spray 50mcg

Class 2 pharmacy level medicines recall – Ranitidine film-coated tablets 150mg and 300mg Medreich PLC

Class 2 pharmacy level medicines recall – Levothyroxine oral solution 100mcg/5ml Wockhardt UK Ltd

Class 2 pharmacy level medicines recall – Ranitidine tablets 150mg and 300mg Medley Pharma Limited

Class 2 pharmacy level medicines recall – Ranitidine 150mg and 300mg Accord Healthcare – EL (19)A/40

Class 2 pharmacy level medicines recall – Emerade® solution for injection pre-filled syringe 150mcg, 300mcg and 500mcg – Action within 48 hours

Class 2 pharmacy level medicines recall – Paracetamol tablets 500 mg M&A Pharmachem Ltd – Action within 48 hours

Class 2 pharmacy level medicines recall – Action within 48 hours – Ranitidine tablets 75mg

Class 2 pharmacy level medicines recall – Action within 48 hours – ranitidine products

Class 3 medicines recall – Action within five days: Folic acid tablets 5mg (Accord UK Ltd)

Class 2 pharmacy level medicines recall– Action within 48 hours – Sandoz Limited Omeprazole powder for solution for infusion 40mg (EL(19)A/34)

Class 2 pharmacy level medicines recall – Action within 48 hours – Kyowa Kirin Limited Mitomycin-C Kyowa , all strengths

Class 2 pharmacy level medicines recall– Action within 48 hours – M&A Pharmachem Limited Paracetamol 500 mg Tablets (EL(19)A/32)

Class 2 medicines recall – Action within 48 hours – Nutriflex Omega products (various)

Class 2 pharmacy level medicines recall – Action within 48 hours – OTC ranitidine preparations

Class 2 medicines recall – Action within 48 hours – Pharmacy level recall: Ranitidine oral solution 150mg/10ml EL (19)A/29

Class 2 pharmacy level medicines recall – Sayana® Press suspension for injection 104mg/0.65ml

Class 2 pharmacy level medicines recall – Action within 48 hours – Ranitidine effervescent tablets 150mg and 300mg

Class 2 pharmacy level medicines recall for Zantac (POM) products

Class 2 medicines recall – pharmacy level recall – Aripiprazole oral solution 1mg/ml

Class 2 pharmacy level medicines recall – Action within 48 hours – Aripiprazole oral solution 1mg/ml

Class 4 Medicines Defect Information – Paracetamol oral suspension 250mg/5ml (Rosemont Pharmaceuticals Ltd)

Class 4 Medicines Defect Information: Zamadol SR prolonged-release hard capsules 50mg

Class 4 FMD Medicines information – multiple products

Class 4 Medicines Defect Information – Aripiprazole 1mg/ml Oral Solution 

Class 4 Medicines Defect Information – Oxylan Prolonged-release tablets, all strengths

Class 4 Medicines Defect Information – Caution In Use – Memantine film-coated tablets 10mg

Class 4 drug alert – Ibuprofen tablets 400mg Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd

Class 4 medicines defect information – Caution in Use – Diamorphine Hydrochloride BP Lyophilisate for Solution for Injection 100mg

Class 4 medicines defect information – Atrolak XL prolonged-release tablets

Class 4 drug alert – Missing PIL for specific batches of finasteride tablets 5mg

Class 4 drug alert – Caution in Use – Zapain tablets 30mg/500mg (codeine phosphate /paracetamol)

Supply disruption for Convulex® (valproic acid) capsules – all strengths

Emerade® – supply disruption alert

Influenza season 2019/20 – antiviral prescribing

Slo-phyllin® (theophylline) capsules – all strengths discontinued

Supply disruption for all formulations of generic ranitidine – update 27 November 2019

Supply disruption for all oral preparations of generic ranitidine

Class 4 drug alert – Caution in Use – Xonvea gastro-resistant tablets 10mg/10mg

Class 4 drug alert – Caution in Use – Rifadin (rifampicin) capsules 150mg

Class 4 Drug Alert: Caution in Use – Emerade® solution for injection pre-filled syringe 150mcg, 300mcg and 500mcg

Important: EpiPen® 0.3mg adrenaline auto-injectors extended use beyond expiry dates for specific lot numbers

Class 2 Falsified Medicines Directive (FMD) alert: Action within 48 hours – various products imported by B & S Healthcare

Class 4 drug alert – Caution in Use – Phenobarbital Sodium Injection 30mg/ml

Company led recall – Iohexol solution for injection 350mg/1ml and 300mgl/1ml

Company led recall – Paclitaxel concentrate for solution for infusion 6mg/ml

Company led recall – Docetaxel injection 80mg/8ml

Company led recall – Phenytoin oral suspension 90mg/5ml

Diamorphine hydrochloride 5mg and 10mg injection 

Monthly summary of letters and drug alerts that are sent to healthcare professionals and posted on the GOV.UK website

February 2020

January 2020

December 2019

November 2019

October 2019

September 2019

August 2019

Pharmacy drug/device alerts and recalls

NPA support to help pharmacists and pharmacy teams stay up-to-date with drug alerts and recalls

Patient safety alerts

Patient safety alert factsheet and audit sheet

Patient safety

The dedicated NPA webpage for all resources, updates and reports related to patient safety

Alerts and recalls for drugs and medical devices

MHRA webpage for all published alerts and recalls for drugs and medical devices